Stocktoria

Sionna Therapeutics, Inc. SION

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-02-07

Sionna Therapeutics, Inc. statistics & valuation

Market cap$1.9B
P / B6.2×
Return on equity-24.5%
Return on capital-28.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-24.50% 20242025
Shares outstanding
4.7M 44.7M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-33.20% -23.10% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$15.99 -$1.88 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-23.1%-33.2%
Return on equity-24.5%37.7%
Current ratio20.6114.49

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.